A California court again dismisses a shareholder lawsuit accusing Align Technology and its executives of insider trading and securities fraud.
Align Technology (NSDQ:ALGN) announced this month that a California district court again dismissed a shareholder lawsuit, this time with prejudice.
Nobel Biocare sues Brazilian rival Neodent, alleging infringement of 2 patents covering its NobelActive dental implants by Neodent's Drive CM devices.
Nobel Biocare doubles its 2nd-quarter profits as it reportedly fields interest – and at least 1 offer worth $2.3 billion – from potential acquirers.
Dentsply and Philips Healthcare land contracts worth a collective $39 million from the U.S. Defense Dept.
Ousted CEO Federico Pignatelli turns the spotlight on new leadership at his former company after resigning from the board of directors.
Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli isn't ready to put down his dukes after dropping his seat on the company's board of directors.
Biolase's scorned former CEO Federico Pignatelli retires from the board of directors, saying that he was effectively forced out by hostilities from other members.
Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli, who was removed from the corner office by a court order earlier this year, also walked away from the company's board of directors.
Scorned Biolase ex-CEO Federico Pignatelli withdraws his lawsuit as the company urges shareholders to welcome new leadership and deny his bid for re-election to the board.
Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli agreed this week to withdraw his lawsuit against the dental devices maker, but he's still pursuing his personal investigation into the company's recent conduct.